Gottesfeld, Joel M.
Funding for this research was provided by:
NIH, NINDS (5R01NS062856)
National Eye Institute (1R01EY026490, 1R01EY029166)
Friedreich’s Ataxia Research Alliance (not known)
BioMarin Pharmaceutical, Inc (not known)
This article is maintained by: Elsevier
Article Title: Molecular Mechanisms and Therapeutics for the GAA·TTC Expansion Disease Friedreich Ataxia
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-019-00764-x
Content Type: article
Copyright: Copyright © 2019 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.